Abstract:Xingyu Chang, 1, &ast Yuchen Kang, 2, &ast Yuxuan Yang, 1, &ast Yajie Chen, 1 Yanyu Shen, 1 Chenjun Jiang, 1 Yi Shen 3 1 The First Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China; 2 The Second Clinical Medical College, Lanzhou University, Lanzhou, People's Republic of China; 3 Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, People's Republic of China &astThese authors contributed equally to this work Correspondence: Yi Shen, Department of Orthopaedics, The Second Xiangya Hospital of Central South University, Changsha, People's Republic of China, Tel +86-13517490910, Email Osteoarthritis (OA) is one of the most common chronic joint diseases and is gradually becoming the main cause of disability and joint pain in the elderly worldwide. Pyroptosis is a regulated programmed cell death triggered by inflammasomes. It leads to cell swelling, lysis, and bioactive molecule secretion. Studies found that the damaged chondrocytes in OA joints had morphological characteristics of pyroptosis, and the cytokines associated with pyroptosis in synovial fluid increased, indicating that pyroptosis may have certain impacts on the pathological progression of OA. This review briefly summarizes the molecular mechanisms of pyroptosis and the epidemiology and pathogenesis of OA. Furthermore, we discussed the role of pyroptosis in articular cartilage and synovium during OA and reviewed the progress of pyroptosis-related molecules in the targeted therapy of OA joints, hoping to provide feasible directions for the diversified treatment of OA. Keywords: pyroptosis, osteoarthritis, articular cartilage, synovium, NLRP3 inflammasome, GSDMD Pyroptosis was first referred to as caspase-1-dependent cell death in mouse macrophages and human monocytes infected with Salmonella Shigella. 1–3 In 2001, this new type of cell death was named 'pyroptosis', which was taken from the Greek roots "pyro" and 'ptosis', meaning "fever" and "fall", respectively. 4 This name aptly indicates the proinflammatory attribute of pyroptosis and therefore clearly distinguishes it from apoptosis. After encapsulating numerous articles over the past decades, the Nomenclature Committee on Cell Death formally defined pyroptosis as a type of regulated cell death (RCD) that is heavily dependent on members of the gasdermin protein family; those proteins form pores in the plasma membrane, and this process is usually (but not always) caused by inflammatory caspases. 5 In recent years, an increasing number of studies have found that pyroptosis occurs in vascular endothelial cells and glial cells. These studies broke down the stereotype that pyroptosis only appears in the mononuclear phagocyte lineage and provided a strong theoretical basis for studying its role in nonimmune diseases, such as cardiovascular diseases and neurodegenerative diseases. 6,7 Osteoarthritis (OA) is the most common degenerative joint disease, affecting approximately 10% of men and 18% of women globally. 8 Although OA is remarkably prevalent, elderly individuals are the most susceptible. 9 OA occurs not only in small joints, such as hand joints but also in giant joints, such as the knee and hip joints. Its pathological changes usually include cartilage degradation, synovial inflammation, subchondral bone sclerosis, and osteophyte formation. 10 At present, most patients with OA are treated with palliative therapy. In the early and middle stages of OA, anti-inflammatory and analgesic therapy combined with exercise rehabilitation is adopted. In the late stage, only joint replacement surgery is available. Therefore, it is urgent to understand OA pathogenesis and formulate corresponding countermeasures. In this review, we summarized the molecular mechanisms of pyroptosis, provided a brief review of osteoarthritis, and explained the role of chondrocyte and synoviocyte pyroptosis in OA-related lesions. Moreover, we reviewed the progress of pyroptosis-related molecules in OA therapy. Since there is no effective targeted treatment for OA at present, exploring the role of pyroptosis and relevant molecules in OA is advantageous for clinical treatment. Pyroptosis is a new type of programmed cell death triggered by inflammasomes and executed by gasdermin family members. 11 Inflammasomes are cytoplasmic protein multimers typically composed of a sensor (pattern recognition receptors; PRRs), an adaptor (apoptosis‐associated speck‐like protein; ASC), and an effector (pro-caspase). Sensors, which are specific pattern recognition receptors (PRRs), mainly include nucleotide-binding oligomerization domains (N -Abstract Truncated-

The effect of pyroptotic in gouty arthritis regulated by NLRP3 and TLR4

Research Progresses of Molecular Mechanism of Pyroptosis and Its Related Diseases

Periplogenin Inhibits Pyroptosis of Fibroblastic Synoviocytes in Rheumatoid Arthritis Through the NLRP3/Caspase-1/GSDMD Signaling Pathway

Mechanistic and therapeutic insights into the function of NLRP3 inflammasome in sterile arthritis

Pyroptosis Plays a Role in Osteoarthritis

Molecular mechanism of pyroptosis and inflammasome activation

The regulatory role and therapeutic application of pyroptosis in musculoskeletal diseases

PPAR-<i></i> Activation Alleviates Osteoarthritis through Both the Nrf2/NLRP3 and PGC-1<i></i>/<i></i><sub>m</sub> Pathways by Inhibiting Pyroptosis

Inflammatory Response to Regulated Cell Death in Gout and Its Functional Implications

Pyroptosis: A New Regulating Mechanism in Cardiovascular Disease

Expression Profile of Pyroptosis-Related Genes and the Associated Regulatory Axis in Primary Gout Patients

Pyroptosis in acute pancreatitis and its therapeutic regulation

Key Genes Associated with Pyroptosis in Gout and Construction of a miRNA-mRNA Regulatory Network

Pyroptosis in health and disease: mechanisms, regulation and clinical perspective

Pyroptosis in Osteoarthritis: Molecular Mechanisms and Therapeutic Implications

Pyroptosis: A pro-inflammatory type of cell death in cardiovascular disease

Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target

Pyroptosis: A Novel Intervention Target in the Progression of Osteoarthritis

Inflammation unleashed: The role of pyroptosis in chronic liver diseases

Pyroptosis, metabolism, and tumor immune microenvironment

Pyroptosis in inflammatory diseases and cancer